Literature DB >> 9124532

Colonic epithelium-enriched protein A4 is a proteolipid that exhibits ion channel characteristics.

G E Breitwieser1, J C McLenithan, J F Cortese, J M Shields, M M Oliva, J L Majewski, C E Machamer, V W Yang.   

Abstract

Expression of the human gene A4 is enriched in the colonic epithelium and is transcriptionally activated on differentiation of colonic epithelial cells in vitro (M. M. Oliva, T. C. Wu, and V. W. Yang. Arch. Biochem. Biophys. 302: 183-192, 1993). A4 cDNA contains an open reading frame that predicts a polypeptide of 17 kDa. To determine the function of the A4 protein, we characterized its biochemical and physiological properties. Hydropathy analysis of deduced A4 amino acid sequence revealed four putative membrane-spanning alpha-helices. The hydrophobic nature of A4 was confirmed by its being extractable with organic solvents. Immunocytochemical studies of cells expressing A4 localized it to the endoplasmic reticulum. Moreover, A4 multimerized in vivo as determined by coimmunoprecipitation experiments. The four-transmembrane topology and biophysical characteristics of A4 suggest that it belongs to a family of integral membrane proteins called proteolipids, some of which multimerize to form ion channels. Subsequent electrophysiological studies of nuclei isolated from microinjected Xenopus laevis oocytes transiently expressing A4 showed the appearance of a 28-pS channel. Thus our studies indicate that A4 is a colonic epithelium-enriched protein localized to the endoplasmic reticulum and that, similar to other proteolipids, A4 multimerizes and exhibits characteristics of an ion channel.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124532     DOI: 10.1152/ajpcell.1997.272.3.C957

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Global topology analysis of pancreatic zymogen granule membrane proteins.

Authors:  Xuequn Chen; Peter J Ulintz; Eric S Simon; John A Williams; Philip C Andrews
Journal:  Mol Cell Proteomics       Date:  2008-08-04       Impact factor: 5.911

2.  Human papillomavirus E5 oncoproteins bind the A4 endoplasmic reticulum protein to regulate proliferative ability upon differentiation.

Authors:  Katarina Kotnik Halavaty; Jennifer Regan; Kavi Mehta; Laimonis Laimins
Journal:  Virology       Date:  2014-02-14       Impact factor: 3.616

3.  Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions.

Authors:  David R Raleigh; Amanda M Marchiando; Yong Zhang; Le Shen; Hiroyuki Sasaki; Yingmin Wang; Manyuan Long; Jerrold R Turner
Journal:  Mol Biol Cell       Date:  2010-02-17       Impact factor: 4.138

4.  Cancer cell proliferation is inhibited by specific modulation frequencies.

Authors:  J W Zimmerman; M J Pennison; I Brezovich; N Yi; C T Yang; R Ramaker; D Absher; R M Myers; N Kuster; F P Costa; A Barbault; B Pasche
Journal:  Br J Cancer       Date:  2011-12-01       Impact factor: 7.640

5.  Reduced expression of proteolipid protein 2 increases ER stress-induced apoptosis and autophagy in glioblastoma.

Authors:  Zichao Feng; Wenjing Zhou; Jiwei Wang; Qichao Qi; Mingzhi Han; Yang Kong; Yaotian Hu; Yulin Zhang; Anbin Chen; Bin Huang; Anjing Chen; Di Zhang; Wenjie Li; Qing Zhang; Rolf Bjerkvig; Jian Wang; Frits Thorsen; Xingang Li
Journal:  J Cell Mol Med       Date:  2019-11-28       Impact factor: 5.310

6.  PLP2-derived peptide Rb4 triggers PARP-1-mediated necrotic death in murine melanoma cells.

Authors:  Vera S C Maia; Rodrigo Berzaghi; Denise C Arruda; Fabrício C Machado; Leticia L Loureiro; Pollyana M S Melo; Alice S Morais; Alexandre Budu; Luiz R Travassos
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

7.  Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases.

Authors:  Richard T Timms; Lidia M Duncan; Iva A Tchasovnikarova; Robin Antrobus; Duncan L Smith; Gordon Dougan; Michael P Weekes; Paul J Lehner
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.